Evidence map›Paper›PMID 42458557›Full record

ArticleJournal of experimental & clinical cancer research : CR2026

Retraction Note: SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.

Changliang Peng, Hui Zhao, Yan Song, Wei Chen, Xiaoying Wang, Xiaoli Liu, Cheng Zhang, Jie Zhao, Ji Li, Guanghui Cheng and 3 more

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Changliang PengDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Hui ZhaoDepartment of Orthopedics, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Yan SongDepartment of Nephrology, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Wei ChenBeijing Institute of Pharmacology and Toxicology, Beijing, China.
Xiaoying WangDepartment of Pathology, The Second Hospital of Shandong University, Shandong University, Jinan, China.
Xiaoli LiuDepartment of Hematology, The Second Hospital of Shandong University, Shandong University, Jinan, China.
Cheng ZhangDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Jie ZhaoDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Ji LiDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Guanghui ChengCentral Research Laboratory, The Second Hospital of Shandong University, Shandong University, Jinan, China.
Dongjin WuDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Chunzheng GaoDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China.
Xiuwen WangDepartment of Orthopaedics, The Second Hospital of Shandong UniversityShandong University, Jinan, China. pclliang@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42458557
PMCPMC13371006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.